PSI CRO: A Global CRO with Local Asia-Pacific Expertise

Choose the CRO you can trust

PSI CRO is a global CRO that understands the Asia-Pacific clinical development landscape and what it takes to help your product achieve global success.

We are headquartered in Switzerland with an operational presence in more than 60 countries, including China, India, Japan, Singapore, South Korea, and Thailand. This means we can be a strategic partner on your schedule while running your study globally, including providing expert regulatory advice to help your product achieve approval from the FDA, EMA, and other key regulatory bodies.

With long-term relationships with more than 3,900 sites worldwide and our machine-learning-powered tools for feasibility and enrollment forecasting, we will recommend the perfect mix of countries and sites for your study. Schedule a meeting with our dedicated Asia-Pacific clinical development team today.

Spotlight: How PSI Works with Local Sites for NGS Testing in China

Spotlight: How PSI Expedites Study Startup Times in India

The PSI Advantage

For the sixth year in a row, PSI CRO has been named a CRO Leadership Award winner in the categories of Expertise, Quality, and Reliability in the Overall (combined Big and Small pharma) respondent group. The CRO Leadership Awards are presented by Life Sciences Leader and Clinical Leader based on research conducted by ISR Reports. The awards recognize CROs that are voted by sponsors to meet or exceed expectations.